Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia.
Esam I Azhar, Alimuddin Zumla
Author Information
- Esam I Azhar: Special Infectious Agents Unit, Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Alimuddin Zumla: Center for Clinical Microbiology, Division of Infection and Immunity, University College London, NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
No abstract text available.
- Ann Saudi Med. 2005 Mar-Apr;25(2):90-3
[PMID: 15977683]
- Ann Thorac Med. 2009 Apr;4(2):50-3
[PMID: 19561924]
- MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9
[PMID: 23051612]
- Clin Infect Dis. 2014 Feb;58(4):e106-9
[PMID: 24248810]
- MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5
[PMID: 25233284]
- J Epidemiol Glob Health. 2016 Jun;6(2):95-104
[PMID: 26368823]
- Int J Risk Saf Med. 2015;27 Suppl 1:S61-2
[PMID: 26639714]
- Ann Thorac Med. 2016 Apr-Jun;11(2):93-102
[PMID: 27168856]
